These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
211 related items for PubMed ID: 37865269
1. Echinacoside regulates PI3K/AKT/HIF-1α/VEGF cross signaling axis in proliferation and apoptosis of breast cancer. Liang H, Yin G, Shi G, Liu Z, Liu X, Li J. Anal Biochem; 2024 Jan 01; 684():115360. PubMed ID: 37865269 [Abstract] [Full Text] [Related]
2. Celecoxib Down-Regulates the Hypoxia-Induced Expression of HIF-1α and VEGF Through the PI3K/AKT Pathway in Retinal Pigment Epithelial Cells. Sun YZ, Cai N, Liu NN. Cell Physiol Biochem; 2017 Jan 01; 44(4):1640-1650. PubMed ID: 29216640 [Abstract] [Full Text] [Related]
3. Exploration of the Effect and Potential Mechanism of Echinacoside Against Endometrial Cancer Based on Network Pharmacology and in vitro Experimental Verification. Shu W, Wang Z, Zhao R, Shi R, Zhang J, Zhang W, Wang H. Drug Des Devel Ther; 2022 Jan 01; 16():1847-1863. PubMed ID: 35734366 [Abstract] [Full Text] [Related]
4. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway. Blancher C, Moore JW, Robertson N, Harris AL. Cancer Res; 2001 Oct 01; 61(19):7349-55. PubMed ID: 11585776 [Abstract] [Full Text] [Related]
5. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Laughner E, Taghavi P, Chiles K, Mahon PC, Semenza GL. Mol Cell Biol; 2001 Jun 01; 21(12):3995-4004. PubMed ID: 11359907 [Abstract] [Full Text] [Related]
6. 4-Hydroxy estradiol but not 2-hydroxy estradiol induces expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor A through phosphatidylinositol 3-kinase/Akt/FRAP pathway in OVCAR-3 and A2780-CP70 human ovarian carcinoma cells. Gao N, Nester RA, Sarkar MA. Toxicol Appl Pharmacol; 2004 Apr 01; 196(1):124-35. PubMed ID: 15050414 [Abstract] [Full Text] [Related]
7. SU5416 inhibited VEGF and HIF-1alpha expression through the PI3K/AKT/p70S6K1 signaling pathway. Zhong XS, Zheng JZ, Reed E, Jiang BH. Biochem Biophys Res Commun; 2004 Nov 12; 324(2):471-80. PubMed ID: 15474452 [Abstract] [Full Text] [Related]
8. The inhibitory effect and mechanism of Resina Draconis on the proliferation of MCF-7 breast cancer cells: a network pharmacology-based analysis. Lv Y, Mou Y, Su J, Liu S, Ding X, Yuan Y, Li G, Li G. Sci Rep; 2023 Mar 07; 13(1):3816. PubMed ID: 36882618 [Abstract] [Full Text] [Related]
9. Plumbagin Suppresses Breast Cancer Progression by Downregulating HIF-1α Expression via a PI3K/Akt/mTOR Independent Pathway under Hypoxic Condition. Jampasri S, Reabroi S, Tungmunnithum D, Parichatikanond W, Pinthong D. Molecules; 2022 Sep 05; 27(17):. PubMed ID: 36080483 [Abstract] [Full Text] [Related]
10. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification. Wang Y, Chu F, Lin J, Li Y, Johnson N, Zhang J, Gai C, Su Z, Cheng H, Wang L, Ding X. J Ethnopharmacol; 2021 Oct 28; 279():114399. PubMed ID: 34246740 [Abstract] [Full Text] [Related]
11. Uncovering the action mechanism of Shenqi Tiaoshen formula in the treatment of chronic obstructive pulmonary disease through network pharmacology, molecular docking, and experimental verification. Qinjun Y, Dandan Y, Hui W, Yating G, Xinheng W, Di WU, Jiabing T, Chuanbo W, Zegeng LI. J Tradit Chin Med; 2024 Aug 28; 44(4):770-783. PubMed ID: 39066538 [Abstract] [Full Text] [Related]
12. Network pharmacology identification and in Vivo validation of key pharmacological pathways of Phyllanthus reticulatus (Euphorbiaceae) leaf extract in liver cancer treatment. Tang Y, Sun L, Wei J, Sun C, Gan C, Xie X, Liang C, Peng C, Wu H, Zheng Z, Pan Z, Huang Y. J Ethnopharmacol; 2022 Oct 28; 297():115479. PubMed ID: 35777610 [Abstract] [Full Text] [Related]
14. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs. Wang H, Tan H, Zhan W, Song L, Zhang D, Chen X, Lin Z, Wang W, Yang Y, Wang L, Bei W, Guo J. J Ethnopharmacol; 2021 Jun 28; 274():114056. PubMed ID: 33771638 [Abstract] [Full Text] [Related]